Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.

NCT00244205 is registered in ClinicalTrials.gov with Copenhagen University Hospital at Herlev as lead sponsor.

NCT NCT00244205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00244205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.
Lead sponsor
Copenhagen University Hospital at Herlev
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2005
Completion date
Not reported
Enrollment
120
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer